✦ LIBER ✦

9004 Vandetanib plus pemetrexed vs pemetrexed as 2nd-line therapy in patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Scribed by Vansteenkiste, J.; Arrieta, O.; Gottfried, M.; Blackhall, F.H.; Raats, J.; Yang, C.H.; Langmuir, P.; Milenkova, T.; Read, J.; de Boer, R.H.

Book ID: 123071227
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71717-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vandetanib Plus Pemetrexed for the Secon

Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial

✍ de Boer, R. H.; Arrieta, O.; Yang, C.-H.; Gottfried, M.; Chan, V.; Raats, J.; de 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 295 KB

9001 Vandetanib plus docetaxel versus do

9001 Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Eberhardt, W.E.E.; Johnson, B.E.; Sun, Y.; Germonpré, P.; Saijo, N.; Zhou, C.; W 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

9005 Vandetanib versus erlotinib in pati

9005 Vandetanib versus erlotinib in patients with previously treated advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Goss, G.D.; Thongprasert, S.; Greco, F.A.; Thomas, M.; Tsai, C.M.; Sunpaweravong 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

57 Pemetrexed vs docetaxel: a phase III

57 Pemetrexed vs docetaxel: a phase III study in patients with advanced non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy

✍ C. Manegold; R. Gervais; K. Aigner; C. Desch; H. Lim; K. Szondy; C. Bagnes; S. P 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 161 KB

6521 POSTER Is pemetrexed more effective

6521 POSTER Is pemetrexed more effective in patients with non-squamous histology? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC)

✍ Peterson, P.; Park, K.; Fossella, F.; Gatzemeier, U.; John, W.; Scagliotti, G. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Maintenance therapy with pemetrexed plus

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

✍ Luis Paz-Ares; Filippo de Marinis; Mircea Dediu; Michael Thomas; Jean-Louis Pujo 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 244 KB